OncoVista Innovative Therapies, Inc. Stock
Equities
OVIT
US68232J1051
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | +9,900.00% |
Sales 2013 | - | Sales 2014 | - | Capitalization | 1.3M 1.78M |
---|---|---|---|---|---|
Net income 2013 | -1M -1.37M | Net income 2014 | -2M -2.74M | EV / Sales 2013 | - |
Net cash position 2013 | 44.9K 61.44K | Net Debt 2014 | 196K 268K | EV / Sales 2014 | - |
P/E ratio 2013 |
-0.75
x | P/E ratio 2014 |
-0.51
x | Employees | 2 |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 2.36K | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- OVIT Stock